“Our goal is to transfer scientific progress to clinical practice much faster and to offer our patients less extensive breast cancer surgery.”
“As physicians, we are convinced that European networking of capable scientists and experts is highly advantageous for our patients.”
“Breast cancer is a complex disease requiring large-scale cross-disciplinary and cross-border research structures to promote individualised treatment and define the crucial equilibrium between benefit and harm of locoregional treatment. Collaborative research has great potential to unify fragmented European perspectives on breast cancer management to the benefit of all European women.”
“Clinical trials have answered questions that changed the way we perform breast surgery today. We have the commitment to keep breast surgical research ongoing cooperating with other groups to be more efficient. Results from these studies will change the way we treat patients in the future. “
“Breast surgery, yet the main issue in breast cancer treatment, can be de-escalated and standardized. Morbidity can be reduced without safety compromise. EUBREAST is the path to achieve this goal in the near future. “
“In this era of in general good breast cancer survival, attention is warranted for reducing morbidity caused by the extensive universal treatment package deals. Reducing morbidity can be achieved by omission of treatments which no longer benefit the patient. “
Chairman: Prof Oreste D Gentilini
Vice-Chairman: Dr Rosa Di Micco
Treasurer: Prof Maria Luisa Gasparri
Chairman: Prof dr Thorsten Kuehn
Vice-Chairwoman: Prof dr Maggie Panys-Paluchowski
Treasurer: Prof dr Nina Ditsch

Pro Bono:
Special thanks to our volunteers and past colleagues:
And in memory of Angelika Jursik